None listed
Conditions
Interventions
Intervention1: Total 5 Products.
Product1 Scalp Essence sample A
Product2 Scalp Essence sample B
Product3 Scalp Essence sample C
Product4 Scalp Essence sample D
Product5 Scalp Essence sample E
Along w
Sponsors
ANGFA CoLtd
Eligibility
Inclusion criteria
Inclusion criteria: • Female subjects in general good health. • Subjects age group 35-59 years. • Subjects willing to give a written informed consent and agree to come for a regular follow up visit. • Subjects willing to abide by and comply with the study protocol. • Subjects have not participated in a similar investigation in the past four weeks. • The subjects in the photo grading hair thinning within class 2 to class 5 (evaluated as per standard photonumeric 6 point scale) • Subjects who agree to have hair wash everyday • Subjects who agree to refrain from oiling hair during study terms (In the case of oiling, hair oiling will be allowed15 cm away from scalp.) • Subjects who agree to refrain from hot iron or perming during study • Subjects who are not on crash dieting • Subjects who agree not to change hair style (hair dyes, perming, etc.) • Subjects willing not to tie hair tightly and stick to one fixed hair style during study terms. • Subjects will not use hair dressing or hair conditioner before coming to study site. • Subjects who agree not to change the brands of currently used hair color, dye, treatment, etc.,if any during the study terms • Subject with wash out of 10 days before every study visit in case subject uses hair coloring products,(as determined by Hair coloring log) • Subjects do not do excess exercise, lack of sleep, crapula, etc. before coming to study site, especially before dates of measurements • Subjects have to keep regular habits about taking foods, exercise, sleep etc. before and during study terms • If subjects are taking vitamin supplements for maintaining their health purpose only, they would not change the frequency until study finishes. • Subjects do not use any hair regrowth product or hair growth product or medicine except test product • When subjects will start intake medicine like cold medicine, they must inform Site about it.
Exclusion criteria
Exclusion criteria: • Subjects who are undergoing hair growth treatment 3 months before starting the study • Subjects who have disorder like eczema, scalp infection, etc at the time of screening. • Subjects who have alopecia areata of scalp hair. • Subjects who have undergone hair straightening using hot iron or chemicals within 3 months. • Subjects who have treatments of actinotherapy or cancer chemotherapy within 6 months before starting study or have a plan to do treatments of them during study terms. Subjects who have alcoholism and psychiatric disorder. • Subjects who use hairpiece during study terms • Subjects who have hair transplant • Subjects who take pharmaceutical product which cause hirsutism or sparsed fur (ex. phenytoin) • A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products. • Subjects on oral medications (e.g. steroids, anti-oxidant) which will compromise the study. • Subjects who are pregnant or become pregnant during study terms, lactating or nursing. Chronic illness which may influence the cutaneous state. • Subjects participating in other similar cosmetic or therapeutic trial or have a plan to participate in other similar cosmetic or therapeutic trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in hair growth and reduction of hair fall in comparison to baseline and other investigational products as determined by Dermatological assessment using photo numeric scale and measurement of hair in shaved area using phototrichogram imaging with caseliteNova.Timepoint: 12 weeks for each subject. | — |
Secondary
| Measure | Time frame |
|---|---|
| -Safety of Investigational products by assessment of site application reaction by dermatologist and subjects. -Improvement in overall condition of hair as assessed by dermatological and subject questionnaire.Timepoint: 12 weeks for each subject. | — |
Countries
India
Contacts
Public ContactDr Mukesh Ramnane
MS Clinical Research Pvt Ltd.
Outcome results
None listed